AGP Picks
View all

Asia Pacific News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Today.

Press releases published on October 6, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
First Atlantic Nickel & Cobalt Raises Total of $13.4 Million with Additional $3.49 Million No-Warrant, Non-Brokered Private Placement at $0.83 per Share, a Premium to Market, to Accelerate Exploration at Pipestone XL Nickel-Cobalt Alloy Project
Zenas BioPharma to Host Virtual R&D Event
Shopify to Announce Third-Quarter 2026 Financial Results
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
Newcore Gold Drilling Intersects 1.16 g/t Gold over 41.0 Metres, Including 2.54 g/t Gold over 13.0 Metres, at the Enchi Gold Project, Ghana
EBC Financial Group at iFX EXPO Asia 2026 covering Markets, Technology, and Industry Dialogue
FREELANDER Details Powertrain, Battery and All-Terrain Technology for International Left-Hand Drive FREELANDER 8
Elong Power Holding Limited Announces First Half 2026 Financial Results
Ellis Martin Report: RUA Gold (RUA.TO) Reports High Grade Gold and Antimony Results at Auld Creek
WUBEN Prime Day 2026 Offers Exclusive Rewards
HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA
RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
Production update and FTSE 250 Index inclusion

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Pacific News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.